Pharmacy Practice

Featured Article

Safety Guidance Remains Sparse for CGTs

The Food and Drug Administration has authorized more than four dozen cell and gene therapy (CGT) products for use in the United States. But without standard national guidance on the safe handling of CGTs, health systems are relying on general recommendations and institutional experience to make these...